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ABSTRACT

Vibrio cholerae, a Gram-negative bacterium found in natural aquatic
environments, is the causative agent of cholera, a severe diarrheal disease most
commonly spread through drinking water. An essential component to this pathogen’s
success and persistence in the environment is its ability to attach to both biotic and
abiotic surfaces via biofilm formation. Biofilms not only aid in surface attachment, but
also provide a barrier that protects and enhances survival. Water-soluble extracts from
the North American cranberry (Vaccinium macrocarpon) were found to dramatically
inhibit V. cholerae biofilm formation at a low concentration of 2mg/ml. This inhibition
was not due to acidification of the growth medium or any bactericidal or bacteriostatic
effects. The biofilm inhibition also appeared to be specific to V. cholerae. Furthermore,
a decrease in biofilm was also observed when water-soluble cranberry extracts (WSCE)
were added after four hours of pre-incubation of the culture statically. The vps operons,
which encode the major component of V. cholerae biofilm, exopolysaccharide, were
significantly down-regulated in the presence of WSCE by qRT-PCR assays. The vps
operons are controlled by a set of transcriptional activators and repressors within a
tangled signaling network and are regulated in a unique cell density dependent manner
known as quorum sensing. To test whether the master quorum-sensing regulator HapR is
involved in this cranberry-mediated anti-biofilm effect, the same biofilm inhibition assay
was conducted in a hapR deletion mutant. A similar level of inhibition was detected,
suggesting that HapR does not appear to be required for the inhibition by WSCE. To
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further confirm this finding, a wild type V. cholerae strain containing a hapR-lacZ fusion
plasmid was used to determine in vivo expression driven by the hapR promoter and
measured by β-galactosidase activities.

Additionally, it was determined that the

intracellular concentration of cyclic diguanylate (c-di-GMP), an important second
messenger used in signal transduction, is significantly reduced in the presence of WSCE.
In summary, the results suggest a potential application of WSCE as an alternative and
safe means in V. cholerae biofilm control.
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CHAPTER ONE
INTRODUCTION

Vaccinium macrocarpon
The North American cranberry (Vaccinium macrocarpon), having numerous
health benefits associated with its consumption, has been well acknowledged by the
public as a functional food. The bioactive compounds that make up the cranberry have
been thoroughly analyzed and their biological properties have been well characterized.
Among the many components that make up this functional food, there is an extremely
high

concentration

of

total

polyphenols

including

flavonols,

flavan-3-ols,

proanthocyanidins, anthocyanins and phenolic acid derivatives (1-4).

Studies have

shown that many of these phytochemical compounds have been linked to various health
benefits (5-8). It has been long known that cranberries have protective properties against
urinary tract infections. This effect was first thought to have been caused simply by
acidification of the urine. More recent studies have shown that the condensed tannins
contained within cranberries, specifically proanthocyanidins, hinder bacterial surface
attachment(9). Cranberries have also been demonstrated to cause down-regulation of
genes encoding outer membrane proteins in Escherichia coli O157:H7 (8). As a result of
the many antimicrobial properties associated with cranberries, some studies have even
suggested the use of these bioactive compounds as a means of overcoming issues related
to the current methods being used to treat human pathogens, such as antibiotics.
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Vibrio cholerae
Vibrio cholerae is a Gram-negative rod shaped bacterium that inhabits a vast
ecological range of brackish and estuarine waters around the world (10-17). It is the
causative agent of a severe diarrheal, and frequently fatal, disease called cholera that
most commonly occurs in the form of an epidemic (18). With an estimated 3-5 million
cholera cases resulting in 100,000 – 120,000 deaths every year, as reported in 2014 by the
World Health Organization, this disease is still endemic in many parts of the developing
world (19). V. cholerae is capable of surviving and adapting under a vast range of
environmental conditions. This has been largely attributed to various adaptive responses,
including the ability to convert into a viable but non-culturable state during unfavorable
conditions, as well as its ability to transition between planktonic and biofilm form (20,
21). In the planktonic form, V. cholerae is extremely motile, traveling at speeds of up to
60 cell-body lengths per second (22). In its biofilm form, V. cholerae acquires an
increased resistance to many environmental stressors such as desiccation, attack by the
immune system, protozoa ingestion, and antimicrobials (23). Biofilms also facilitate in
the attachment to both biotic and abiotic surfaces (20). For these reasons, among others,
biofilm formation is an essential component to this pathogen’s success and persistence in
the environment.

There are five stages of biofilm development: initial attachment,

irreversible attachment, maturation I, maturation II, and dispersion (24). Biofilms not
only aid in surface attachment and survival in the natural environment, they also provide
a barrier that protects and enhances survival in human infection. When V. cholerae
enters the body, it must first survive the acidic environment of the stomach and then
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proceed to attach to the intestinal wall.

Therefore, biofilms are also critical for

transmission and infectivity (25).

Biofilm Regulation in V. cholerae
Unlike many other bacteria, a unique density dependent regulation of biofilm
formation is used in V. cholerae. Biofilm producing genes, as well as virulence factors,
are maximally expressed at low cell density and inversely, virulence factors and biofilm
formation is turned off at high cell density. This unique system is thought to aid in V.
cholerae’s life cycle, allowing it to attach and detach from its human host in order to
transition back to its natural environment (26).
Biofilms are mainly composed of a substance called exopolysaccharide (EPS),
which is termed VPS in V. cholerae. VPS is synthesized by enzymes encoded by the vps
genes; vpsA-K, in the vpsI operon, and vpsL-Q, in the vpsII operon (27, 28). There are
also numerous matrix proteins encoded in the vps intergenic region, termed rbmA-F
(rugosity and biofilm structure modulators), responsible for the maintenance of biofilm
structure and stability (28-30). The two vps operons are positively regulated by two
transcriptional regulators, VpsR and VpsT (25), which are regulated through a complex
set of quorum sensing pathways comprised of at least three sensory systems, two of
which are well studied (26).

The first sensory system is used for intra-species

communication and has two key genes, cqsA and cqsS, that are required for the
biosynthesis and detection of cholera autoinducer-1 (CAI-1), respectively (26, 31-33).
The second sensory system is used for inter-species communication and has three key
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genes, luxS and luxP/luxQ, required for the synthesis and detection of autoinducer-2 (AI2), respectively (32, 34). The information from these two quorum-sensing systems feed
into a response regulator called LuxO (26). LuxO, in association with the alternative
sigma factor σ54, controls the transcription of genes encoding five small regulatory
RNAs, Qrr1-5 (35), which regulate the two master quorum-sensing regulators in V.
cholerae, AphA and HapR (36). These two master regulators control the expression of
numerous genes involved in virulence and biofilm formation. Studies have also shown
that hapR expression leads to a decrease in concentration of the nearly ubiquitous second
messenger molecule, c-di-GMP, which has recently been recognized as a key component
of V. cholerae’s signaling system (37).
In V. cholerae, c-di-GMP regulates several cellular processes including biofilm
formation and virulence factor production.

The intracellular level of c-di-GMP is

regulated by proteins containing GGDEF and/or EAL domains, which function as
diguanylate cyclases (DGC’s) and phosphodiesterases (PDE’s), respectfully (37-44).
Studies have shown that high levels of c-di-GMP can strongly induce biofilm production
by directly binding with the transcriptional regulator VpsR, which then activates vpsT
and aphA transcription (43). Together, c-di-GMP and the quorum-sensing pathway are
two important regulatory systems that collectively control the activation and repression of
biofilm formation and virulence factor expression in V. cholerae.
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Significance
In the current study, we seek to understand the molecular mechanisms of this
cranberry-mediated inhibition of V. cholerae biofilm. It was found that when static
cultures of V. cholerae were exposed to WSCE, at a concentration of 2mg/ml, biofilm
formation was significantly inhibited. This inhibition was not due to acidification of the
growth medium or any bactericidal or bacteriostatic effects. The biofilm inhibition also
appears to be specific to V. cholerae. A decrease in biofilm formation was also observed
when WSCE was added to a pre-established static culture of V. cholerae. Four key genes
in the quorum-sensing pathway (cqsA, luxS, luxO and hapR) were then tested and shown
to be uninvolved in the WSCE-mediated biofilm inhibition. Furthermore, qRT-PCR
assays reveal that both of the vps operons were significantly down-regulated in the
presence of WSCE. Interestingly, vpsR, which encodes the transcriptional activator for
vpsI and, indirectly, vpsII is not down-regulated. Additionally, it was determined that the
intracellular concentration of an important second messenger used in signal transduction,
cyclic diguanylate (c-di-GMP), is significantly reduced in the presence of WSCE. It is of
particular relevance that c-di-GMP is required as a cofactor for the proper function of
VpsR. Moreover, this study has the potential to provide an alternative means of V.
cholerae biofilm control as well as an alternative treatment method for cholera.
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CHAPTER TWO
MATERIALS AND METHODS

Bacterial Strains and Media
The bacterial strains used in this study are listed in Table 2.1. The V. cholerae,
Pseudomonas aeruginosa, Salmonella typhimurium and Escherichia coli strains were
cultured in Luria-Bertani (LB) medium.

The Staphylococcus aureus, Enterococcus

faecalis and Listeria monocytogenese strains were cultured in brain-heart infusion (BHI)
medium. When performing inoculations for overnight cultures, streptomycin (100µg/ml)
was used for antibiotic selection of all V. cholerae C6706 strains.

Streptomycin

(100µg/ml) and tetracycline (1µg/ml) was used for antibiotic selection of all V. cholerae
C6706 strains carrying the pBB1 plasmid.

When using strains carrying the pBB1

plasmid for luminescence assays cultures were always maintained at 25°C or 30°C. All
biofilm formation assays were incubated at 25°C under static conditions.
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Table 2.1. Strains used in this study
Strain Name
V. cholerae C6706
(O1 El Tor) Strains
CO-15
CO-17
CO-18
CO-19
CO-22
CO-23
CO-24
CO-25
CO-26
Other Strains
CO-4 (S. aureus)
CO-5 (P. aeruginosa)
CO-12 (S. typhimurium)
CO-13 (E. faecalis)
CO-14 (E. coli O157:H7)
CL-74 (L. monocytogenese ScottA)
CL-2 (L. monocytogenese MAC)
(45)
(34)
(34)
(34)
(26)
(34)
(34)
(34)
(46)
ATCC# 25923
ATCC# 27853
ATCC# 14028
ATCC# 47077
ATCC# 700927
Lab stock
(47)

Wild Type
Wild Type/pBB1
luxO-/pBB1
hapR-/pBB1
luxOC
cqsAluxSluxS-/cqsAPhapR-LacZ fusion
None
None
None
None
None
Serotype 4b
Serotype 1/2a
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Source or Reference

Relevant Characteristics

Preparation of Water-Soluble Cranberry Extracts
The cranberry extract (CBE) used in this study was received from DECAS
Cranberry Products, Inc. and referred to as HI-PAC BL DMAC 5. Lab stocks of CBE
were received in lyophilized form and stored at -80°C. Working solutions of CBE were
prepared as needed by dissolving the CBE power in water at a 5% concentration (w/v).
The solution was then centrifuged at 16,000 x RPM for 5 minutes in order to remove all
non-water-soluble components.

The supernatant, containing only WSCE, was then

collected and used for treatments at the desired concentration.

Isolation of Planktonic Cells
Many experiments in this study focused on observing the cells transition phase,
i.e., when the transformation from planktonic form to biofilm form was induced. This
required the collection of only planktonic cells from samples, in which a mature biofilm
had been formed, while collecting as few biofilm cells as possible. The planktonic cells
were isolated from biofilm cells by first gently vortexing the test tube in order to detach
the biofilm pellicle from the test tube wall.

Next, the test tube was angled at

approximately 45 degrees and rotated so that the biofilm pellicle would attach completely
to the side of the test tube wall. Once this was done, the test tube was angled up right,
leaving the planktonic cells exposed and the biofilm pellicle remaining attached to the
side of the test tube wall. The planktonic cells were then collected using a pipette.
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Crystal Violet Assay
Crystal violet assays were used as an initial means of quantifying biofilm and
measuring the inhibition that was caused by WSCE treatment. It served as a quick and
simple screening technique to measure biofilm inhibition as a result of various WSCE
treatment concentrations. The crystal violet assay was later replaced with the standard
plate count method to more accurately quantify biofilm formation as CFUs/ml. The
crystal violet assays were conducted using both 96-well plates and polystyrene test tubes.
1:100 dilutions of overnight cultures were inoculated into 1ml of LB in polystyrene test
tubes using V. cholerae strains wild type, luxO- and hapR-. Each culture was treated with
WSCE at concentrations of 0mg/ml (control) and 2mg/ml. Biofilms were allowed to
form by incubating the cultures at 25°C for 24 hours under static conditions. Stains were
observed, photographed, dissolved in DMSO, and quantified at OD570.

Biofilm Inhibition Assay
Overnight cultures of V. cholerae were inoculated into 1ml of LB in polystyrene
test tubes (1:100 dilution) using V. cholerae strains wild type, cqsA-, luxS-, luxS-/cqsA-,
luxOc, luxO- and hapR-. Each culture was treated with WSCE at concentrations of
0mg/ml (control) and 2mg/ml. Biofilms were allowed to form by incubating the cultures
at 25°C for 24 hours under static conditions. First, samples of planktonic cells were
plated onto LB agar plates at appropriate dilutions. Then, the planktonic cells were
removed, biofilms were washed with 1X PBS, and resuspended in 1ml of ddH2O.
Before biofilm samples were plated onto LB agar, 3-5 1mm glass beads were added to
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each sample and agitated for two minutes using a vortex to disrupt the biofilm pellicle.
LB agar plates containing both planktonic and biofilm samples were incubated at 37°C
overnight, colonies were counted and CFU’s were calculated.

Experiments were

conducted in triplicates. P-value’s were determined by Student’s t test.

Growth Curve
Cultures were grown overnight for 10 hours at 30°C and rotary shaking at 150
RPM.

Samples were then diluted so that each culture had an equal cell density

(approximately 1:1000). WSCE was added at a concentration of 2mg/ml. 50mL of
diluted culture was incubated at 25°C under static conditions for 24 hours. Samples were
plated hourly and quantified using the standard plate count method.

Pre-established Biofilm Inhibition Assay
Overnight cultures of V. cholerae were inoculated into 1ml of LB in polystyrene
test tubes (1:100 dilution). Cultures were incubated under static conditions at 25°C for 4
hours in order to allow the cultures to reach phase I of biofilm establishment. After 4
hours samples were treated with WSCE, at a concentration of 2mg/ml, and reincubated at
25°C under static conditions for the remaining 20 hours. First, samples of planktonic
cells were plated onto LB agar plates at appropriate dilutions. Then, the planktonic cells
were removed, biofilms were washed with 1X PBS, and resuspended in 1ml of ddH2O.
Before biofilm samples were plated onto LB agar, 3-5 1mm glass beads were added to
each sample and agitated for two minutes using a vortex to disrupt the biofilm pellicle.
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LB agar plates containing both planktonic and biofilm samples were incubated at 37°C
overnight, colonies were counted and CFU’s were calculated.

Experiments were

conducted in triplicates. P-values were determined by Student’s t test.

Motility Assay
Overnight cultures of V. cholerae were inoculated into 1ml of LB in polystyrene
test tubes (1:100 dilution). Cultures were incubated with rotary shaking at 150rpm at
37°C for 5 hours and then 2µl samples of each strain were dropped onto motility plates
containing 0.3% agar. Plates were incubated in the dark at room temperature for 12
hours and then photographed and observed for motility.

Hydrophobicity Assay
Overnight cultures of V. cholerae were inoculated into 1ml of LB in glass test
tubes (1:100 dilution) in replicates of three. Cultures were grown at 25°C and rotary
shaking at 150 RPM for 24 hours. Samples were then transferred to 1.5ml eppendorf
tubes and washed twice with 0.85% NaCl at 8,000 x g for 2 minutes. Samples were then
transferred to glass test tubes and resuspended in 3ml of 0.85% NaCl. Spectrophotometer
readings were then measured for each sample at 600nm and recorded as the OD Initial.
Next, 0.25ml of toluene was added to each sample and vortexed for 2 minutes. Samples
were then permitted to equilibrate for 30 minutes, allowing the toluene phase to separate
from the aqueous phase. Spectrophotometer readings were then measured from the
aqueous phase of each sample at 600nm and recorded as the OD Final.
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The

Hydrophobicity Index (HPBI) was then calculated using the following formula: (OD
Initial - OD Final)/OD Initial*100%=HPBI. Experiments were conducted in triplicates.
P-values were determined by Student’s t test.

Luminescence Assay
Cultures were grown overnight for 10 hours at 30°C and 150 RMP. Samples
were then diluted so that each culture had an equal cell density (approximately 1:1000).
WSCE was added at a concentration of 2mg/ml. 50mL of diluted culture was incubated
at 25°C under static conditions for 24 hours.

Every hour samples collected and

luminescence was measured using a BioTek® Synergy H1TM Hybrid Multi-Mode
Microplate Reader.

Beta-galactosidase Assay
Overnight cultures of V. cholerae were inoculated into 1ml of LB in polystyrene
test tubes (1:100 dilution) in triplicate.

Cultures were grown at 25°C, under static

conditions, and samples were collected at 4h, 8h, 16h and 24h time-points, representing
key phases of growth based on our growth curve. In order to observe the expression of
hapR during the cells transition phase, which would induce the transformation of a cell
from planktonic form to biofilm form, only planktonic cells were collected from the
samples. Samples were lysed and ortho-Nitrophenyl-β-galactosidase (ONPG) was used to
measure the level of beta-galactosidase within the cell. Experiments were conducted in
triplicates. P-values were determined by Student’s t test.
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Quantitative Real Time-PCR
Overnight cultures of V. cholerae were inoculated into 1ml of LB in polystyrene test
tubes (1:100 dilution) in triplicate. Cultures were grown at 25°C, under static conditions.
Samples were collected at 4h and 24h time-points, representing early and late stages of
biofilm development. In order to observe the gene expression during the cells transition
phase, which would induce the transformation of a cell from planktonic form to biofilm
form, only planktonic cells were collected from the samples. All RNA samples were
prepared using RNAzol RT reagent (Molecular Research Center, INC.) and stored at 80°C. Complementary DNA was synthesized using the BioRad iScriptTM cDNA
synthesis kit. qPCR was performed using SensiFAST SYBR No-Rox Kit (Bioline) and
the CFX96 real-time PCR detection system according to the manufacturer’s suggested
protocol (Bio-Rad). The qPCR conditions were: 95°C for 3 minutes, followed by 40
cycles of 5 s at 95°C, 10 s at 50°C and 15 s at 72°C. Relative fold-changes for transcripts
were calculated using the comparative CT (2-∆∆CT) method. Cycle thresholds of
amplification were determined by Light Cycler software (Bio-Rad). Each qRT-PCR
experiment was repeated three times using independent RNA preparations. The data were
pooled and analyzed using unpaired Student’s t-test, and p<0.05 was accepted as
statistically significant. The qPCR primers used in this study are listed in Table 2.2.
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Table 2.2 Oligos used in this study
Name
16S rRNA-F
16S rRNA-R
luxO-F
luxO-R
hapR-F
hapR-R
vpsR-F
vpsR-R
vpsT-F
vpsT-R
vpsD-F
vpsD-R
vpsL-F
vpsL-R
epsE-F
epsE-R
mshA-F
mshA-R
cdgA-F
cdgA-R
cdgB-F
cdgB-R
cdgC-F
cdgC-R
cdgD-F
cdgD-R
rmbA-F
rmbA-R
rmbB-F
rmbB-R
rmbC-F
rmbC-R
bap1-F
bap1-R
flaA-F
flaA-R
pomB-F
pomB-R

Sequence
5'-GGA AAC GAT GGC TAA TAC CG-3'
5'-GCC CTT ACC TCA CCA ACT AG-3'
5'-GCG AAA GTG GTA CAG GTA AAG-3'
5'-CCC TTT GAC GTG ACC AAA C-3'
5'-CGA TTG TCA CTG GCT CAA AG-3'
5'-GCA GTT GGT TAG TTC GGT TG-3'
5'-GGC CAT GTA TTG GTA TTG TGG-3'
5'-GGC AAA TGG TAT CTG AAC TGA G-3'
5'-GTC CGC AGG ATA TTG AGC AT-3'
5'-GCC TTT GAT CAG GGT ATC CA-3'
5'-CAT CCA AGA GCA ACT GAA AG-3'
5'-GCA AGG TCA ACA CAT TAC GAG-3'
5'-TTC TTT ACA TAC GGC ATT C-3'
5'-GCC AAT AAA AGA ACC GAC-3'
5'-CTA ACC CAA GTC TAT CAG-3'
5'-AAT CTT CGT TTT GAG GC-3'
5'-CAT TGC CCA TAA GTT TG-3'
5'-GTT CCT GTA GAC GAT TG-3'
5'-GTT TAC TGA GAT GCT GG-3'
5'-GCT CAT ATT TCA CCA TCA C-3'
5'-GCC AAT CCT GAA ATT CTG-3'
5'-AAC CGA CCA GAT AAG AG-3'
5'-TTC TCA ACC GAC TAC AC-3'
5'-CGA TCT GCT CCA TAA AAC-3'
5'-GGA TAG ACA AGG AAA AGA AC-3'
5'-GTC GTT TGA GCA GAT TC-3'
5'-TGG GTT CCA GAG TAT ATG-3'
5'-GAG TTC AGG TAG GCT ATT-3'
5'-CAG CAG GAA CAG AAA TG-3'
5'-CCT TAG CTC CTC TAG TAT C-3'
5'-CGA AGCA ATA AGA AAG TGG-3'
5'-GCC TTC AAC TAA CCA AC-3'
5'-CGC TGG CAC ACT AAA CAA G-3'
5'-CCA TAC ATT CAT ACC CAA GAG C-3'
5'-GGA TTA AAG ATA CGG ATT TTG-3'
5'-CGA GAT TGC AGA GTT TG-3'
5'-CTC TTG CTC TCG TTT TC-3'
5'-AAT ACT GGT CCC TTT GG-3'
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C-di-GMP Quantification
Recently, a group of chemists devised a way to quantify c-di-GMP concentration
using a fluorescent dye called Thiazole Orange (TO). They found that c-di-GMP can
exist in different aggregate forms when monovalent cations are present in solution (1M
NaCl). TO can then form complexes with these aggregates and can be detected by
fluorescence using excitation and emission wavelengths of 508nm and 557nm,
respectively (48). Using this method, c-di-GMP levels were quantified in samples of V.
cholerae that were treated with WSCE and compared to control samples. Overnight
cultures were inoculated into 1ml of LB in polystyrene test tubes (1:100 dilution) in
quintuplicate. Cultures were grown at 25°C, under static conditions, and samples were
collected at 4h, 8h, 16h and 24h time-points, representing key phases of growth based on
our growth curve. In order to observe the change in c-di-GMP concentration during the
cells transitional phase, which would induce the transformation of a cell from planktonic
form to biofilm form, only planktonic cells were collected from samples.

During

collection, five 1ml samples were concentrated into a single 0.8ml sample, by 6.25x.
Cells were then lysed by sonication at 30W for 60 seconds (three 20 second pulses),
trichloroacetic acid (TCA) was used to precipitate cellular macromolecules and
centrifugation was used to separate the precipitate. The remaining cell lysate, containing
only small molecules, was collected and filtered through a 0.2µm filter. A sample of the
cell lysate was then diluted 1:10 into a buffer (10mM Tris-HCL (pH 8.0) containing 1M
NaCl), incubated at 95°C for 5 minutes, and cooled to room temperature. TO was then
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added to each sample at a working concentration of 30µM and incubated at 4°C for 12h
and fluorescence readings were then taken.

The concentration of c-di-GMP was

calculated using a calibration curve. Experiments were conducted in triplicates. P-values
were determined by Student’s t test.
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CHAPTER THREE
RESULTS
WSCE At Very Low Concentration (2mg/ml) Inhibit
Biofilm Formation Without Affecting Bacterial Growth
The formation and inhibition of biofilm was first observed in a test tube as a
significant reduction in pellicle size, shown in Figure 3.1-A. The inhibition was then
measured, both qualitatively and quantitatively, using a test tube crystal violet assay and
the standard plate count method, shown in Figures 3.1-B, C and D. When wild-type V.
cholerae is treated with WSCE the production of biofilm is significantly reduced in a
density dependent manner, shown in Figure 3.1-C. Our results, shown in Figure 3.1-D,
indicated that when wild-type V. cholerae was treated with WSCE at concentrations
greater than 3mg/ml cell viability began to decrease significantly in a density dependent
manner. When conducted in parallel, these two studies revealed that WSCE, at a very
low concentration (2mg/ml), inhibited biofilm formation without affecting bacterial
growth. To further confirm that WSCE treatment did not affect bacterial growth, a 24hour growth curve was conducted, (Figure 3.1-E).
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Figure 3.1. Effect of WSCE on biofilm formation and cell viability. (A) Biofilm pellicles
formed by V. cholerae C6706 in the absence and presence of WSCE. (B) Crystal violet
staining results of V. cholerae C6706 biofilm in the absence and presence of WSCE.
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Figure 3.1. Effect of WSCE on biofilm formation and cell viability. (C) Crystal violet
staining results of V. cholerae C6706 biofilm in the presence of various concentrations of
WSCE. (D) Twenty-four-hour static growth of V. cholerae C6706 in the presence of
various concentrations of WSCE.
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Figure 3.1. Effect of WSCE on biofilm formation and cell viability. (E) Twenty-fourhour growth curve of V. cholerae C6706 in the presence and absence of WSCE at a final
concentration of 2mg/ml.
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WSCE-Mediated Biofilm Inhibition Is Specific To Vibrio cholerae
Biofilm formation was compared among eight different bacterial species treated
with WSCE in order to determine the effects on various bacterial pathogens. Cells in
both planktonic form and biofilm form were isolated, quantified separately using the
standard plate count method, and then compared. The results shown in Figure 3.2 reveal
that WSCE-mediated biofilm inhibition is specific to V. cholerae.
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Figure 3.2. Quantification of biofilm formation in V. cholerae C6706 and seven other
bacterial species in the absence and presence of WSCE. ** indicates p < 0.001.
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WSCE Treatment Does Not Affect Motility or Initial Surface Attachment
A motility assay was conducted on V. cholerae in the absence and presence of
WSCE. The results shown in Figure3.3-A indicate that the motility of V. cholerae is not
affected by WSCE. Next, these results were confirmed by testing the gene expression of
an important flagellar structural gene, flaA, and an important flagellar motor gene, pomB,
using qRT-PCR. Figure 3.3-B shows no significant decrease in gene expression of either
flaA or pomB in the presence of WSCE. A pre-established biofilm inhibition assay was
then conducted in order to determine the effect of WSCE on initial surface attachment.
The results shown in Figure 3.3-C indicate that WSCE treatment can inhibit and reverse
the maturation of a pre-established biofilm, suggesting that WSCE does not affect initial
surface attachment. Lastly, these results were confirmed by testing the gene expression
of mshA, using qRT-PCR. As shown in Figure 3.3D, the gene expression of mshA does
not appear to be affected by the presence of WSCE.
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Figure 3.3. (A) Motility assay on 0.3% soft agar plate. (B) Quantitative real-time PCR
analysis of flagellar structural and motor genes, flaA and pomB.
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Figure 3.3. (C) Bacterial cultures were allowed to pre-establish for 4 hours before treated
with WSCE. (D) Quantitative real-time PCR analysis of type IV pilus attachment gene,
mshA. * indicates p < 0.05.
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WSCE Mainly Affects The Development Phase of Biofilm Formation
Studies have shown that reducing the CSH of bacterial cells would be an effective
method for inhibiting biofilm formation (49, 50). A reduction in CSH can be interpreted
as a reduction in EPS production (51). Using a hydrophobicity assay, the CSH was
calculated and compared between WSCE-treated and non-treated cultures of V. cholerae.
CSH was significantly reduced in cultures grown in the presence of WSCE after 24
hours, indicating that WSCE causes a decrease in EPS production. Using qRT-PCR, the
expression level of various genes encoding proteins responsible for the regulation and
synthesis of biofilm were quantified and compared between WSCE-treated and nontreated cultures of V. cholerae. Genes within the vpsI and vpsII operons, vpsD and vpsL
respectively, were down-regulated in the presence of WSCE. Genes encoding biofilm
matrix proteins bap1, rmbA, rmbB and rmbC were also down-regulated. As would be
expected, vpsT, the transcriptional activator for the vpsII operon was down-regulated.
However, the transcriptional activator for vpsT and the vpsI operon, vpsR, was not downregulated. cdgB, cdgC and cdgE, three genes encoding diguanylate cyclases (DGC’s),
proteins responsible for the synthesis of c-di-GMP, were down-regulated. Results were
quantitated using the delta-delta Ct method.
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Figure 3.4 WSCE affects the development phase of biofilm formation. (A) CSH is
significantly reduced in cultures grown in the presence of WSCE. Samples were
collected after 24-hours. * indicates p < 0.05.

27

Figure 3.4 WSCE affects the development phase of biofilm formation. (B) qRT-PCR
analyses of some V. cholerae biofilm-related genes. Samples were collected after 4hours.
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Figure 3.4 WSCE affects the development phase of biofilm formation. (C) qRT-PCR
analyses of some V. cholerae biofilm-related genes. Samples were collected after 24hours. * indicates p < 0.05, and ** indicates p < 0.001.
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WSCE-Mediated Biofilm Inhibition Occurs Independent of hapR
Using wild type V. cholerae and the following knockout and overexpression
mutant strains: cqsA-, luxS-, luxS-/cqsA-, luxOc, luxO- and hapR-; four key genes within
the quorum-sensing pathway (cqsA, luxS, luxO and hapR) were tested for their
involvement by conducting biofilm inhibition assays. If biofilm formation were restored
in any of the mutant strains while exposed to WSCE, the gene that was mutated would be
presumed to be involved in the WSCE-mediated biofilm inhibition. Figure 3.5-A shows
that none of the key genes tested are involved in the WSCE-mediated biofilm inhibition.
Considering the importance that is placed on HapR in the regulation of biofilm
formation in V. cholerae, two assays were conducted to test the expression level of hapR
in WSCE treated cultures. The first assay utilizes a strain of V. cholerae containing a
hapR-lacZ transcriptional fusion. The second method is a luminescence assay. This assay
utilizes a strain of V. cholerae that contains a plasmid harboring the luminescence
operon, which is positively regulated by HapR. An increase or decrease in luminescence,
relative to the control, will correlate with an increase or decrease in the expression of
hapR. To ensure that the WSCE was not interfering with the luminescence detection, a
strain of V. cholerae that constitutively expresses luminescence was run in parallel.
Results in Figure 3.5-B showed that hapR expression was significantly reduced in
cultures treated with WSCE.

This result was also confirmed in Figure 3.5-C.
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Figure 3.5. WSCE-Mediated Biofilm Inhibition Occurs Independent of hapR. (A)
Quantification of 24-hour V. cholerae biofilm formation of the wt (C6706), luxS-, cqsA-,
luxS-/cqsA-, luxOC, luxO- and hapR- strains. ** indicates p < 0.001.
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Figure 3.5. WSCE-Mediated Biofilm Inhibition Occurs Independent of hapR. (B) In vivo
expression driven by the hapR promoter in V. cholerae wt strain as measured by βgalactosidase activities. ** indicates p < 0.001, * indicates p < 0.05.
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Figure 3.5. WSCE-Mediated Biofilm Inhibition Occurs Independent of hapR. (C) 24hour expression of hapR measured by luminescence.
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WSCE treatment reduces the intracellular concentration of c-di-GMP
Using thiazole orange, c-di-GMP levels were quantified in samples of V. cholerae
that were treated with WSCE and compared to control samples at 4h, 8h, 16h and 24h.
Figure 3.6-A shows that the intracellular concentration of c-di-GMP was significantly
reduced at 16h and 24h.

34

Figure 3.6. WSCE treatment reduces the intracellular concentration of c-di-GMP (A)
Quantification of intracellular [c-di-GMP] in V. cholerae C6706 in the absence and
presence of WSCE, K=100,000,000. (B) Calibration curve (equation for trendline: y =
5.2415x2 - 37.046x - 695.83). ** indicates p < 0.001
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WSCE causes down-regulation of numerous genes required for virulence expression
Using qRT-PCR, the expression level of numerous genes encoding proteins
responsible for the regulation and synthesis of virulence factors were quantified and
compared between WSCE-treated and non-treated cultures of V. cholerae C6706. Figure
3.7 shows numerous genes required for virulence factor expression were down-regulated
in the presence of WSCE.
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Figure 3.7. qRT-PCR analyses of some V. cholerae virulence-related genes. * indicates p
< 0.05, and ** indicates p < 0.001.

37

CHAPTER FOUR
DISCUSSION

Cholera and Treatment
V. cholerae is the causative agent of cholera, and is most commonly spread
through inadequate drinking water and leads to severe dehydration and death in some
cases. With over 3 million cases of cholera reported worldwide each year, this disease is
still endemic in many parts of the developing world. Current treatment methods for
cholera infection involve rehydration and antibiotic supplementation. As antibiotic use is
becoming increasingly ineffective, due to the selective pressure it places on resistant
strains of bacteria, the need to develop alternative treatment methods is becoming
extremely important. This study provided data that supports the continued investigation
for the use of WSCE as an alternative means of V. cholerae biofilm control as well as an
alternative method of treatment for cholera. For WSCE to be used as a treatment for
cholera, ideally more analytical work should be conducted in an attempt to narrow the list
of active components. Alternatively, the WSCE powder could be used as a supplement in
addition to salt hydration packets. Implementing this type of treatment would be both
convenient and economical, considering hydration packets are already a major treatment
method for cholera patients. In addition to a potential application for treatment, this
study also provides added insight into the complexity of the quorum sensing system, and
the role of c-di-GMP as an important second messenger in biofilm and virulence
regulation.
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C-di-GMP and Biofilm Formation
Recent studies from our lab revealed that V. macrocarpon could protect against V.
cholerae infection in the nematode model system, Caenorhabditis elegans (52). In the
present study, the effects of WSCE on V. cholerae biofilm formation were investigated.
The production and excretion of exopolysaccharide and biofilm matrix proteins plays an
essential role in the survival, transmission and infection of this pathogen.

The

exopolysaccharide used for biofilm formation is synthesized by enzymes encoded by the
vps genes; vpsA-K, in the vpsI operon, and vpsL-Q, in the vpsII operon (27, 28). In this
study, vpsD was used to represent the expression of the vpsI operon, and vpsL was used
to represent the expression of the vpsII operon. The biofilm matrix proteins are encoded
by genes in the vps intergenic region, termed rbmA-F, responsible for the maintenance of
biofilm structure and stability (28-30). In this study, rmbA, rmbB, rmbC and bap1 are
used to measure the expression of biofilm matrix proteins. Bap1 is a matrix protein that
facilitates the adherence of the developing biofilm to surfaces (29). Another important
regulator of biofilm formation is c-di-GMP (37-41, 53). Three genes encoding DGC’s,
cdgB, cdgC and cdgE, have been shown to regulate expression of genes required for V.
cholerae polysaccharide synthesis and of the transcriptional regulator genes vpsR, vpsT
and hapR (41, 44). Studies have shown that high levels of c-di-GMP can strongly induce
biofilm production by directly binding with the transcriptional regulator VpsR, which
then activates vpsT and aphA transcription (43). The two vps operons, vpsI and vpsII, are
positively regulated by two transcriptional regulators, VpsR and VpsT, respectively (25).
Results from this study, shown in Figure 3.4, indicate that the transcriptional activator
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protein VpsR is being produced in the presence of WSCE. However, considering that cdi-GMP is required as a cofactor for the proper function of VpsR, the transcriptional
activator protein is not able to activate vpsT (and indirectly the vpsII operon) or the vpsI
operon, ultimately restricting the pathway and drastically reducing biofilm production
(43). Moreover, the results from this study show that a significant reduction in biofilm
formation can be attributed to a decrease in the intracellular [c-di-GMP], leading to an
overall decrease in the expression of genes within the vpsI and vpsII operons (Figure 3.4
and 3.6). A model of the complex regulation of biofilm production by c-di-GMP is
shown in Appendix A.

Cell Surface Attachment
There are five stages of biofilm formation: initial attachment, irreversible
attachment, maturation I, maturation II, and dispersion (24, 54). The model for biofilm
formation is shown in Appendix B. These five stages can be further simplified into two
potential phases that WSCE could be affecting: the attachment phase and the
development phase. During the first phase of attachment the cell is highly dependent
upon motility, which requires the expression of two important genes: flaA, which encodes
a flagellum structural protein, and pomB, which encodes a flagellum motor protein (55).
Once the cell reaches close proximity to a surface, the cell requires expression of mshA,
which encodes the pilin protein for a mannose sensitive hemaglutinin type IV pilus that is
essential during initial attachment to abiotic surfaces (ie. test tube) (20). Taken together,
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the results from this study shown in Figure 3.3 suggest that WSCE does not appear to be
affecting the attachment phase of biofilm formation.

The Quorum-Sensing System
The quorum-sensing pathway has been well established in published literature as
being one of the major pathways responsible for biofilm regulation in V. cholerae (25,
26, 31-33, 37, 43, 56-64). In recent literature, the protein HapR has been termed the
master regulator of the quorum-sensing regulatory system in V. cholerae, and a hapRmutant has been shown to have an increased biofilm-forming capacity (26, 53, 63, 65).
Based on previous studies showing that an increase in hapR expression causes a decrease
in biofilm formation, we would expect to find an increase in hapR expression linked to
the biofilm inhibition observed in our WSCE treated cultures (26). Interestingly, the
results from Figure 3.5 show a decrease in hapR expression, indicating that WSCEmediated biofilm inhibition occurs independent of the master-quorum sensing regulator
HapR and its upstream regulator LuxO. These findings not only expand upon the current
understanding of biofilm regulation in V. cholerae, they place emphasis on its complexity
and the potential involvement of other regulatory mechanisms. A model of the complex
regulation of biofilm production by quorum-sensing is shown in Appendix A.

Future Directions
Results from this study also indicate that the expression of numerous genes
involved in the regulation and production of virulence factors are significantly reduced in
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the presence of WSCE (Figure 3.7). The two key factors essential for virulence during
infection are the toxin-coregulated pilus (TCP) and cholera toxin (CT) (66, 67). The TCP
is a type IV pilus that is required for colonizing the small intestine, and CT is an
enterotoxin responsible for inducing cholera symptoms (66, 67). The transcriptional
regulator, ToxT, positively regulates the expression of these two virulence factors (68).
A model of the complex regulation of virulence factor expression by quorum-sensing and
c-di-GMP is shown in Appendix A.
In order to expand upon the potential inhibitory effects WSCE has on V. cholerae
virulence expression, further in vitro infection assays should be conducted using cell lines
HT-29, HEP-G2 and CHO-K1. Before conducting infection assays, however, an MTT
assay should be conducted to determine the in vitro growth inhibition effect, if any, of
WSCE on each of the cell lines using a range of concentrations ranging slightly above
and below 2mg/ml. When conducting the infection assays, each of the cell lines should
be maintained until confluence, washed with 1X PBS and then resuspended in their
respective medium (69). Cultures should be infected with V. cholerae at a multiplicity of
infection (MOI) of ~100, with and without WSCE, and then a proliferation assay should
be conducted (69).
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Regulation of Biofilm and Virulence by Quorum-Sensing and c-di-GMP

Appendix A
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Model of Biofilm Formation
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